Dopamine release is impaired in a mouse model of DYT1 dystonia

Journal of Neurochemistry

Volumn 102, Issue 3, 2007, Pages 783-788

  Balcioglu, Aygul ^a   Kim, Mee Ohk ^a   Sharma, Nutan ^a   Cha, Jang Ho ^a   Breakefield, Xandra O ^a   Standaert, David G ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Dopamine; DYT1 dystonia; HPLC; In vivo microdialysis; Mouse; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DIHYDROTETRABENAZINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; EMONAPRIDE; MAZINDOL; POSTSYNAPTIC RECEPTOR; PROTEIN TORSIN A; TRITIUM; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DYSTONIA; EXPERIMENTAL MODEL; GENE; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; METABOLITE; MICRODIALYSIS; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TOR 1A GENE; TRANSGENIC MOUSE; TRANSPORT KINETICS;

ANIMALS; BINDING, COMPETITIVE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DYSTONIA MUSCULORUM DEFORMANS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIGANDS; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; MUTATION; PRESYNAPTIC TERMINALS; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; SYNAPTIC TRANSMISSION; TRANSGENES;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 34447303772     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04590.x     Document Type: Article

References (37)

1. Asanuma K., Ma Y., Okulski J., Dhawan V., Chaly T., Carbon M., Bressman S. B. Eidelberg D. (2005) Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64, 347 349.
2. Augood S. J., Martin D. M., Ozelius L. J., Breakefield X. O., Penney J. B. Jr. Standaert D. G. (1999) Distribution of the mRNA encoding torsinA abd torsinB in the normal adult human brain. Ann. Neurol. 46, 761 769.
3. Augood S. J., Hollingsworth Z., Albers D. S., Yang L., Leung J., Breakefield X. O. Standaert D. G. (2004) Dopamine transmission in DYT1 dystonia. Adv. Neurol. 94, 53 60.
4. Balcioglu A., Zhang K. Tarazi F. I. (2003) Dopamine depletion abolishes apomorphine and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats. A microdialysis study. Neuroscience 119, 1045 1053.
5. Bressman S. B., Raymond D., Wendt K., Saunders-Pullman R., De leon D., Fahn S., Ozelius L. Risch N. (2002) Diagnostic criteria for dystonia in DYT1 families. Neurology 59, 1780 1782.
6. Cao S., Gelwix C. C., Caldwell K. A. Caldwell G. A. (2005) Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 25, 3801 3812.
7. Carboni E., Spielewoy C., Vacca C., Nosten-Bertrand M., Giros B. Di Chiara G. (2001) Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J. Neurosci. 21, 1 4.
8. Cha J. J., Kosinski C. M., Kerner J. A., Alsdorf S. A., Mangiarini L., Davies S. W., Penney J. B., Bates G. P. Young A. B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc. Natl Acad. Sci. USA 95, 6480 6485.
9. Dang M. T., Yokoi F., McNaught K. P., Jengelley T. A., Jackson T., Li J. Li Y. (2005) Generation and characterization of Dyt1 λGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196, 452 463.
10. Dang M. T., Yokoi F., Pence M. A. Li Y. (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 56, 470 474.
11. Franklin K. B. Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic press, Burlington, MA, USA.
12. Furukawa Y., Hornykiewicz O., Fahn S. Kish S. J. (2000) Striatal dopamine in early-onset primary torsin dystonia with the DYT1 mutation. Neurology 54, 1193 1195.
13. Ghilardi M. R., Carbon M., Silvestri G., Dhawan V., Tagliati M., Bressman S., Ghez C. Eidelberg D. (2003) Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann. Neurol. 54, 102 109.
14. Ichinose H, Ohye T., Takahashi E. et al. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature. Genet. 8, 236 242.
15. Jankovic J. Fahn S. (1993) Dystonic disorders, in Parkinson's Disease and Movement Disorders (Jankovic J. Tolosa E., eds pp. 337 374. Williams and Wilkins, Baltimore.
16. Klien C., Ozelius L. J. Breakefield X. O. (2007) Genetic evaluation in primary dystonia, in Handbook of Dystonia (Stacy M. ed pp. 21-44. Informa Healthcare, New York.
17. Knappskog P. M., Flatmark T., Mallet J., Ludecke B. Bartholome K. (1995) Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381 K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 1209 1212.
18. Kuczenski R., Segal D. S. Todd P. K. (1997) Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology 134, 221 229.
19. Leung J. C., Klein C., Friedman J. et al. (2001) Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 3, 133 143.
20. Lupas A., Flagan J. M., Tamura T. Baumeister W. (1997) Self-compartmentalization proteases. Trends Biochem. Sci. 22, 399 404.
21. McNaught K. S., Kapustin A., Jackson T., Jengelley T. A., Jnobaptiste R., Shashidharan P., Perl D. P., Pasik P. Olanow C. W. (2004) Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 56, 540 547.
22. Misbahuddin A., Placzek M. R., Taanman J. W., Gschmeissner S., Schiavo G., Cooper J. M. Warner T. T. (2005) Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Dis. 20, 432 440.
23. Mizoguchi K., Yuzurihara M., Nagata M., Ishige A., Sasaki H. Tabira T. (2002) Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment. Pharmacol. Biochem. Behav. 72, 723 728.
24. Neuwald A. F., Aravind L., Spouge J. L. Koonin E. V. (1999) AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 27 43.
25. Ogura T. Wilkinson A. J. (2001) AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 6, 575 597.
26. Ogura T., Ogata M., Akita H., Jitsuki S., Akiba L., Noda K., Hoka S. Saji M. (2005) Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease. Neurosci. Res. 51, 299 308.
27. Ozelius L. J., Hewett J., Page C. et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 17, 40 48.
28. Rostasy K., Augood S. J., Hewett J. W., Leung J. C., Sasaki H., Ozelius L. J., Ramesh V., Standaert D. G., Breakefield X. O. Hedreen J. C. (2003) TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 12, 11 24.
29. Rouge-Pont F., Usiello A., Benoit-Marand M., Gonon F., Piazza P. V. Borrelli E. (2002) Changes in extracellular dopamine-induced by morphine and cocaine: crucial control by D2 receptors. J. Neurosci. 22, 3293 3301.
30. Rupniak N. M., Jenner P. Marsden C. D. (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88, 403 419.
31. Sharma N., Baxter M. G., Petravicz J., Bragg C. D., Schienda A., Standaert D. G. Breakefield X. O. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 5351 5355.
32. Shashidharan P., Sandu D., Potla U., Armata I. A., Walker R. H., McNaught K. S., Weisz D., Sreenath T., Brin M. F. Olanow C. W. (2005) Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genetics 14, 125 133.
33. Skidmore F. Reich S. G. (2005) Tardive dystonia. Curr. Treat. Options Neurol. 7, 231 236.
34. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
35. Torres G. E., Sweeney A. L., Beaulieu J. M., Shashidharan P. Caron M. G. (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant. Proc. Natl Acad. Sci. USA 101, 15650 15655.
36. Vacher C. M., Gassmann M., Desrayaud S., Challet E., Bradaia A., Hoyer D., Waldmeier P., Kaupmann K., Pevet P. Bettler B. (2006) Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. J. Neurochem. 97, 979 991.
37. Westerink B. H. C. (1995) Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70, 103 124.